Ado-trastuzumab emtansine and Lutetium Lu 177 dotatate
Determining the interaction of Ado-trastuzumab emtansine and Lutetium Lu 177 dotatate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: lutetium lu 177 dotatate
Brand name: Lutathera
Synonyms: Lutetium Lu 177 Dotatate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Lutetium lu 177 dotatate Intravenous
- Ado-trastuzumab emtansine-Luvox
- Ado-trastuzumab emtansine-Luvox CR
- Ado-trastuzumab emtansine-Luxiq
- Ado-trastuzumab emtansine-Lybrel
- Ado-trastuzumab emtansine-Lyderm
- Lutetium Lu 177 dotatate-Ado-trastuzumab emtansine Intravenous
- Lutetium Lu 177 dotatate-Adox Pak 2/100
- Lutetium Lu 177 dotatate-Adoxa
- Lutetium Lu 177 dotatate-Adoxa CK
- Lutetium Lu 177 dotatate-Adoxa Pak
- Lutetium Lu 177 dotatate-Adoxa Pak 1/100